Loading…

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children

Abstract Objectives Bacille Calmette-Guerin (BCG), a live attenuated Mycobacterium bovis vaccine, poses a risk to human immunodeficiency virus (HIV)-infected children; this risk has not been well quantified. We estimate the risk of disseminated BCG disease in HIV-infected children in a setting highl...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2007-01, Vol.25 (1), p.14-18
Main Authors: Hesseling, Anneke C, Marais, Ben J, Gie, Robert P, Schaaf, H. Simon, Fine, Paul E.M, Godfrey-Faussett, Peter, Beyers, Nulda
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objectives Bacille Calmette-Guerin (BCG), a live attenuated Mycobacterium bovis vaccine, poses a risk to human immunodeficiency virus (HIV)-infected children; this risk has not been well quantified. We estimate the risk of disseminated BCG disease in HIV-infected children in a setting highly endemic for tuberculosis and HIV. Design and methods We conducted a prospective hospital-based surveillance study in the Western Cape Province, South Africa. Clinical and laboratory-confirmed cases of disseminated BCG disease in children
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2006.07.020